AMENDMENT NO. 5 TO AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • February 1st, 2023 • Invox Pharma LTD • Pharmaceutical preparations
This AMENDMENT NO. 5 TO AGREEMENT AND PLAN OF MERGER (this “Amendment”) is entered into as of January 31, 2023, by and among invoX Pharma Limited, a private limited company under the laws of England and Wales (“Parent”), Fennec Acquisition Incorporated, a Delaware corporation and a wholly owned subsidiary of Parent (“Purchaser”), and F-star Therapeutics, Inc., a Delaware corporation (the “Company” and together with Parent and Purchaser, the “Parties”).
